Evidence map›Paper›PMID 42871835›Full record

ArticleOpen forum infectious diseases2026

High Mortality in Adults With Community-Acquired Pneumonia Admitted to Hospitals in South Africa Before and During the COVID-19 Pandemic, Stratified by HIV Serostatus and Viral Load: Data From a Prospective Cohort Study (2019-2021).

Nadia Sabet, Firdaus Nabeemeeah, Kennedy Otwombe, Khuthadzo Hlongwane, Lebohang M Mlambo, Tumelo Moloantoa, Michelle Wong, Phetho Mangena, Pattamukkil Abraham, Floris Swanepoel and 11 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Nadia SabetPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.ORCID https://orcid.org/0000-0001-9402-0974
Firdaus NabeemeeahPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Kennedy OtwombePerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Khuthadzo HlongwanePerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Lebohang M MlamboPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Tumelo MoloantoaPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Michelle WongDepartment of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Phetho MangenaDepartment of Internal Medicine, University of Limpopo, Polokwane, South Africa.
Pattamukkil AbrahamPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Floris SwanepoelPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Anne von GottbergCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.ORCID https://orcid.org/0000-0002-0243-7455
Cheryl CohenSchool of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.ORCID https://orcid.org/0000-0003-0376-2302
Mignon du PlessisCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.ORCID https://orcid.org/0000-0001-9186-0679
Jo SouthernMedical Evidence Development Vaccines, Chief Medical Affairs Office, Pfizer Inc, Collegeville, Pennsylvania, USA.
Mark A FletcherPfizer Vaccines Research & Development, Medical Affairs, International Emerging Markets, Paris, France.
Eileen M DunneMedical Evidence Development Vaccines, Chief Medical Affairs Office, Pfizer Inc, Collegeville, Pennsylvania, USA.ORCID https://orcid.org/0000-0001-5542-0780
Bradford D GessnerMedical Evidence Development Vaccines, Chief Medical Affairs Office, Pfizer Inc, Collegeville, Pennsylvania, USA.
Bha Ndungane-TlakulaPfizer, Johannesburg, South Africa.
Minja MilovanovicPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.ORCID https://orcid.org/0000-0002-4654-8755
Ebrahim VariavaPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.ORCID https://orcid.org/0000-0003-2888-789X
Neil A MartinsonPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Community-acquired pneumonia (CAP) is a leading cause of death in adults, but recent data in people with HIV (PWH) are lacking. We studied South African adults hospitalized with CAP to describe mortality and risk factors. Methods: We prospectively enrolled consenting adults aged ≥18 years hospitalized with CAP, as defined by symptoms, signs, and chest x-ray, from March 2019 to October 2021 in 3 South African hospitals. Blood, sputum, nasopharyngeal/oropharyngeal swabs, and urine were tested for HIV, tuberculosis, SARS-CoV-2, influenza, respiratory syncytial virus, and Results: Of 2000 adults (median age, 46 years), 1079 (54.0%) were PWH. Among 994 with HIV viral load results, 289 (29.1%) were virally suppressed, and among 1556 tested for SARS-CoV-2, 700 (45.0%) were positive. There were 569 (28.5%) deaths, and the majority died early: 47.7% during hospitalization and 10.6% ≤30 days postdischarge. Leading underlying causes of death were COVID-19 (23.0%), tuberculosis (16.9%), and advanced HIV (13.2%). Age ≥45 years (hazard ratio, 2.7; 95% CI, 1.5-4.6), active tuberculosis (1.6, 1.2-2.0), unsuppressed HIV viral load (1.4, 1.0-1.9), anemia (1.3, 1.0-1.6), underweight (1.3, 1.0-1.7), and low admission oxygen saturation (<94% on room air; 1.3, 1.0-1.6) were associated with mortality. Mortality was higher in PWH (18.2 vs 11.7 per 100 person-years) but similar between PWH who were virally suppressed and unsuppressed (21.3 vs 24.7 per 100 person-years). Conclusions: In-hospital and postdischarge CAP mortality remains high, particularly among PWH, regardless of virologic status, warranting urgent investigation of mitigation strategies.

Indexed as

community-acquired pneumoniaCOVID-19HIVmortalitytuberculosis

Identifiers

PMID42871835
PMCPMC13660697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.